Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Frontotemporal Degeneration: early-phase trial registry
2 of 3 indexed Frontotemporal Degeneration trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Frontotemporal Degeneration: 3 US clinical trials tracked, 2 recruiting.
Frontotemporal Degeneration is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is The Methodist Hospital Research Institute, running 1 of these trials.
Enrollment posture brief
Registry condition frontotemporal-degeneration
OPEN 2 | RECR 67% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Frontotemporal Degeneration lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Frontotemporal Degeneration on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Frontotemporal Degeneration is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
Johns Hopkins University
NCT06604520
IL-2 Plus Abatacept in FTD
The Methodist Hospital Research Institute
NCT06395038
Telehealth-enabled Integrated Palliative Care for People With Dementia
Thomas Jefferson University
NCT05524181
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Frontotemporal Degeneration records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Frontotemporal Degeneration trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Frontotemporal Degeneration page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Frontotemporal Degeneration trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The Methodist Hospital Research Institute sponsors the most Frontotemporal Degeneration trials on record, review their full trial history before evaluating a specific study. See The Methodist Hospital Research Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Frontotemporal Degeneration condition card totals 3 registered trials; most-linked intervention Telehealth Integrated Primary Care (TIPC); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.